The Kano State Drugs and Medical Consumables Supply Agency (DMCSA) has raised its working capital to ₦377,033,845 after successfully settling an inherited debt of ₦102,238,600 between 2023 and 2025.
The Director of Drugs and Supply, Pharmacist Tukur Ibrahim, disclosed this while briefing newsmen shortly after the 8th Quarterly Review Meeting held at the agency’s conference hall on Monday.
He described the achievement as a major milestone under the leadership of the agency’s Director-General, Pharmacist Ghali Sule, noting that the DMCSA has significantly restored its credibility and operational efficiency since December 2023.
Read Also:
Kano Govt Approves N233 Million for Procurement of Laboratory Equipment for DMCSA
According to him, the agency has almost completed the settlement of outstanding liabilities owed to pharmaceutical companies that supply essential drugs to Kano State hospitals.
“This debt clearance was achieved through the monthly Drug Revolving Fund accountability sessions introduced by the current leadership. These meetings help identify challenges, review progress, and strengthen transparency,” Tukur explained.
He further noted that the accountability and reform initiatives led by the Director-General have boosted the agency’s reputation among development partners and pharmaceutical suppliers.
“You see, the negative debt we inherited from the past administration weakened our operations. But under close supervision and collaboration among all key units — including the Drugs Management System, Procurement, and Financial Operations — we were able to recover and settle over ₦1 billion in old debts,” he said.
Speaking earlier, the Director-General, Pharmacist Ghali Sule, commended Governor Abba Kabir Yusuf’s administration for its steadfast support toward revitalising the agency’s operations.
He explained that the state government now releases ₦40 million daily to support hospitals across Kano, compared to ₦10 million under previous arrangements.
“This increase covers the free Maternal, Newborn and Child Health (MNCH) programme as well as drug supplies to correctional centres in the state,” he added.
Sule revealed that the agency has expanded its logistics capacity with new vehicles to enhance drug distribution to zonal stores and health facilities across the state.
He also disclosed that the agency’s long-delayed Pharma Grade Store project is now complete and ready for use, while the DMCSA has been fully registered with the Pharmaceutical Council of Nigeria (PCN) and enrolled in a takaful insurance scheme to strengthen operational sustainability.
The Director-General appealed to the state government to further increase the agency’s capital base to enhance revenue generation, efficiency, and the overall effectiveness of DMCSA’s drug supply system.
